French drugmaker Sanofi (NASDAQ:SNY) on Wednesday said it had agreed to settle about 4K lawsuits in all U.S. states outside of Del. over accusations that its Zantac heartburn drug caused cancer.

Feb 25 (Reuters) - Boehringer Ingelheim has prevailed in the trial of two lawsuits claiming that its discontinued heartburn drug Zantac caused cancer, both of which had previously ended with hung ...

All the companies have insisted they will defend themselves vigorously in the lawsuits ... or reliable evidence that ranitidine increases the risk of any cancer.” “Yesterday’s ruling ...

NEW YORK CITY, NY / ACCESS Newswire / March 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

the FDA requested that manufacturers cease selling Zantac and any generic alternatives. Tens of thousands of cancer-stricken patients filed personal injury and product liability lawsuits against ...

LOS ANGELES, CA / ACCESS Newswire / February 28, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of ...

GSK claims to investors that its decision to remove Zantac ... of cancer in patients.” The Company admitted it could not "quantify or reliably estimate the liability" it would face from lawsuits ...

Boehringer Ingelheim has prevailed in the trial of two lawsuits claiming that its discontinued heartburn drug Zantac caused cancer, both of which had previously ended with hung juries. November 22 ...

The UK-based pharmaceutical company has been the target of numerous lawsuits ... causes cancer, and that the company failed to warn users that its main ingredient—ranitidine—may be a human ...

A class action lawsuit has already been filed ... is no evidence of a causal association between ranitidine therapy and the development of cancer in patients," findings that were "consistent ...